Mitre Medical

Mitre_Medical_LOGO_HI-REZ

Mitre Medical Receives FDA Approval For the ENRAPT-US Early Feasibility Study

The Mitral Touch Empowers Surgeons to Treat Functional MR on a Beating Heart Mitre Medical is pleased to announce concurrent to the PCR-London Valves Conference that the FDA has determined Mitre Medical Corp. has provided sufficient data to support initiation of a human clinical study to evaluate the safety and performance of the Mitral Touch … Read more

Structural Heart Treatment Meets Structural Heart Imaging: Mitre Medical Announces Partnership with Laralab

New AI-based CT Imaging Helps Screen and Assess Patients for the Mitral Touch Epicardial Clip Mitre Medical Corp. and Laralab UG have partnered to provide surgeons with the most advanced 3D epicardial models ever made prior to surgery. This software has also provided the assessment of the Mitral Touch’s performance in heart failure patients in … Read more

Minimally Invasive Delivery of the Mitral Touch and 1-Year Follow-Up of the ENRAPT-MR Study will be Presented at EACTS 2019 Techno College

The Mitral Touch Represents a Breakthrough in the Surgical Treatment of Heart Failure The Mitral Touch is an epicardial clip designed to reduce mitral regurgitation and provide subvalvular support of the left ventricle for functional mitral regurgitation (FMR) patients. The ENRAPT-MR study investigated the safety and performance of the Mitral Touch during concomitant treatment of … Read more

Edwards Announces 6-Month Pascal Results – Eyes MitraClip Market

PARIS, May 22, 2019 — Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, announced strategic clinical and regulatory milestones for its Edwards PASCAL transcatheter valve repair system. Today at the EuroPCR annual course in Paris, new 6-month data from the CLASP study of the PASCAL … Read more

A meta-analysis of the COAPT and MITRA-FR Results changes the way we look at MR & the LV in heart failure.

Silicon Valley, December, 2018 – Proportionate and Disproportionate Functional Mitral Regurgitation A New Conceptual Framework That Reconciles the Results of the MITRA-FR and COAPT Trials Paul A. Grayburn, Anna Sannino and Milton Packer Read full article here: http://imaging.onlinejacc.org/content/early/2018/11/28/j.jcmg.2018.11.006

Transcatheter Mitral-Valve Repair in Patients with Heart Failure

Silicon Valley, September, 2018 – COAPT: MitraClip Reduces Repeat Hospitalizations, Mortality in Functional MR Patients With Severe HF. Physicians responded with shock and excitement to findings, but struggled to reconcile the results with the MITRA-FR trial. Read article here:  https://www.nejm.org/doi/full/10.1056/NEJMoa1806640 Gregg W. Stone, M.D. et al. for the COAPT Investigators*  

Mitre Medical Corp. to Present a Beating Heart Option for Functional MR Repair and Will Present 6-Month Results from the ENRAPT-MR Trial at Two Upcoming European Cardiac Surgery Conferences.

Silicon Valley, September 7, 2018 –Mitre Medical has been invited to introduce the Mitral Touch epicardial annuloplasty system that enables a beating heart option for the surgical treatment of mitral regurgitation during the 9 September Innovator’s Day poster session, as part of the PCR London Valves meeting, to be held 9–11 September in London, UK.  … Read more